These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 2428660
1. [Effects of epsilon-aminocaproic acid, amben and kontrikal on fibrinolysis due to tissue-type plasminogen activator from the pig heart]. Shimonaeva EE, Andreenko GV, Alieva NI. Farmakol Toksikol; 1986; 49(4):35-8. PubMed ID: 2428660 [Abstract] [Full Text] [Related]
2. [Effect of synthetic and natural inhibitors on the activity of tissue activator from the swine heart in vitro]. Andreenko GV, Shimonaeva EE, Alieva NI. Vopr Med Khim; 1986; 32(4):45-7. PubMed ID: 2429443 [Abstract] [Full Text] [Related]
3. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis. Thorsen S, Astrup T. Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113 [No Abstract] [Full Text] [Related]
4. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus). Gogjian MA, Barry KJ, Stein BM. Lab Anim Sci; 1981 Dec 31; 31(6):710-1. PubMed ID: 7343767 [Abstract] [Full Text] [Related]
5. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Nielsen VG, Cankovic L, Steenwyk BL. Blood Coagul Fibrinolysis; 2007 Jan 31; 18(1):35-9. PubMed ID: 17179824 [Abstract] [Full Text] [Related]
6. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid. Thorsen S, Kok P, Astrup T. Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):325-40. PubMed ID: 4450189 [No Abstract] [Full Text] [Related]
7. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid. Worowski K. Acta Biol Acad Sci Hung; 1976 Dec 31; 27(2-3):125-8. PubMed ID: 140568 [Abstract] [Full Text] [Related]
8. [Study of the effect of a dexamethasone-containing antirheumatic on the hypothalomus-adenohypophysis-adrenocortical system]. Jaeger H, Russmann D, Schlegel E, Tzonev I. Arzneimittelforschung; 1982 Dec 31; 32(11):1489-96. PubMed ID: 6295416 [Abstract] [Full Text] [Related]
9. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals]. Shimonaeva EE, Andreenko GV. Vopr Med Khim; 1988 Dec 31; 34(1):59-62. PubMed ID: 3130724 [Abstract] [Full Text] [Related]
17. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J. Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138 [Abstract] [Full Text] [Related]
18. Enhancement of fibrinolysis in rabbits exposed to low and moderate levels of carbon monoxide inhibited by epsilon amino caproic acid. Kalmaz EV, Canter LW, Coleman RL, Hampton JW. Thromb Haemost; 1978 Feb 28; 39(1):109-21. PubMed ID: 580486 [Abstract] [Full Text] [Related]
20. The effect of dexamethasone on tissue fibrinolytic system in male and female rats. Tsantarliotou M, Taitzoglou I, Kokolis N. In Vivo; 1999 Feb 28; 13(2):119-24. PubMed ID: 10363166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]